ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,937 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryZugCelldex Therapeutics Switzerland GmbH
Celldex Therapeutics Switzerland GmbH Logo
Verified· 2 sourcesTrust Score
Summary

About the company

Celldex Therapeutics Switzerland GmbH is a biopharmaceutical company developing antibody-based immunotherapies. Its pipeline includes barzolvolimab, a humanized monoclonal antibody antagonist of KIT, and CDX-622, a bispecific antibody targeting TSLP and SCF, aimed at treating allergic, inflammatory and autoimmune conditions.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered3
Antibody-based therapeutics
Antibody-based immunotherapies and development programs, including monoclonal and bispecific antibodies, discovery, engineering and GMP manufacturing for inflammatory, allergic and autoimmune diseases.
Development of therapies for inflammatory, allergic and autoimmune diseases
Development of drug candidates for chronic spontaneous urticaria, cold urticaria, symptomatic dermographism, prurigo nodularis, atopic dermatitis and other inflammatory and fibrotic diseases.
Bispecific antibody platform
Bispecific antibody programs and a platform for neutralising TSLP and mast cells, as a basis for further candidates in inflammatory diseases.
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Celldex Therapeutics Switzerland GmbH

Trust & reputation

ranQ Trust Score of Celldex Therapeutics Switzerland GmbH: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

Celldex Therapeutics Switzerland GmbH has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Celldex Therapeutics Switzerland GmbH scores 80.8 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.79.212%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.82.07%
Celldex Therapeutics Switzerland GmbH scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Celldex Therapeutics Switzerland GmbH scores 100.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Celldex Therapeutics Switzerland GmbH reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Celldex Therapeutics Switzerland GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Celldex Therapeutics Switzerland GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Celldex Therapeutics Switzerland GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Celldex Therapeutics Switzerland GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Gotthardstrasse 28
6302 Zug

At a glance

Legal form
Limited Liability Company
UID
CHE-151.632.228
Founded
2018 · 8 years
Last commercial register change
April 4, 2018
Employees
21 to 50
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.88.06%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    EA
    Elthera AG
    Zug
    CT
    CRISPR Therapeutics AG
    Zug
    IP
    IPSEN Pharma Schweiz GmbH
    Zug
    CL
    Centenara Labs AG
    Baar
    MI
    MoonLake Immunotherapeutics AG
    Zug
    AM
    Advanced Microbiotics AG
    Zug
    NI
    Noveeda International GmbH
    Zug
    PG
    Pharvaris GmbH
    Zug